Literature DB >> 7501462

Catalytic site-specific cleavage of a DNA-target by an oligonucleotide carrying bleomycin A5.

D S Sergeyev1, T S Godovikova, V F Zarytova.   

Abstract

Oligonucleotide reagents have been created which are capable of catalytic site-specific cleavage of DNA-targets. The oligonucleotide reagent Blm-R-pd(CCAAACA) bearing the bleomycin A5 (Blm-RH) residue was used to degrade the DNA-target pd(TGTTTGGCGAAGGA). It has been shown that at equimolar reagent: target concentration the bleomycin oligonucleotide derivative can repeatedly cleave the target at G9, G7, T5, T4 and T3 in site-specific manner. This paper demonstrates that with a 10-fold excess of the DNA-target relative to the reagent 30% degradation of the target was observed primarily at a single position G7. The paper also shows that one reagent molecule containing bleomycin A5 residue was capable to degrade three molecules of the DNA-target. The catalytic activity of Blm-R-pd(CCAAACA) was the highest in the temperature range close to the melting temperature of the reagent-target complex, that is under conditions where the oligonucleotide reagent can form a complementary complex and easily dissociate to interact with the next molecule of the target. The number of target molecules degraded by the bleomycin reagent is limited by the degradation of the antibiotic residue itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7501462      PMCID: PMC307396          DOI: 10.1093/nar/23.21.4400

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

Review 1.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

2.  Catalytic release of deoxyribonucleic acid bases by oxidation and reduction of an iron.bleomycin complex.

Authors:  L F Povirk
Journal:  Biochemistry       Date:  1979-09-04       Impact factor: 3.162

3.  Absorption and optical rotatory dispersion of seven trinucleoside diphosphates.

Authors:  C R Cantor; I Tinoco
Journal:  J Mol Biol       Date:  1965-08       Impact factor: 5.469

4.  Chemistry of bleomycin. XXI. Metal-complex of bleomycin and its implication for the mechanism of bleomycin action.

Authors:  T Takita; Y Muraoka; T Nakatani; A Fujii; Y Iitaka; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1978-10       Impact factor: 2.649

5.  Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin.

Authors:  A D D'Andrea; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Properties and products of the degradation of DNA by bleomycin and iron(II).

Authors:  E A Sausville; R W Stein; J Peisach; S B Horwitz
Journal:  Biochemistry       Date:  1978-07-11       Impact factor: 3.162

7.  Oxygen transfer from bleomycin-metal complexes.

Authors:  N Murugesan; G M Ehrenfeld; S M Hecht
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

8.  Interaction of bleomycin with DNA.

Authors:  M Takeshita; A P Grollman; E Ohtsubo; H Ohtsubo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin.

Authors:  J Kross; W D Henner; S M Hecht; W A Haseltine
Journal:  Biochemistry       Date:  1982-08-31       Impact factor: 3.162

10.  DNA-like duplexes with repetitions. III. Efficient template-guided chemical polymerization of d(TGGCCAAGCTp).

Authors:  Z A Shabarova; N G Dolinnaya; V L Drutsa; N P Melnikova; A A Purmal
Journal:  Nucleic Acids Res       Date:  1981-11-11       Impact factor: 16.971

View more
  2 in total

1.  HIV latency: present knowledge, future directions.

Authors:  Xavier Contreras; Tina Lenasi; B Matija Peterlin
Journal:  Future Virol       Date:  2006       Impact factor: 1.831

2.  Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.

Authors:  Qian Liu; Nancy Zoellner; David H Gutmann; Kimberly J Johnson
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.